Using BCR-ABL-induced CML-like myelo-proliferative disease mouse model, it was observed that loss of Gadd45b accelerated CML progression and reduced survival of mice. Here, GADD45B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.